Article Information
History
- October 25, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Karen Cardwell1,
- Susan M Smith1,
- Barbara Clyne1,2,
- Laura McCullagh3,4,
- Emma Wallace1,
- Ciara Kirke5,
- Tom Fahey1,
- Frank Moriarty1,* and
- on behalf of the General Practice Pharmacist (GPP) Study Group
- 1HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland
- 2HRB Collaboration in Ireland for Clinical Effectiveness Reviews (HRB-CICER), Health Information and Quality Authority, Dublin, Ireland
- 3National Centre for Pharmacoeconomics, St James’s University Teaching Hospital, Dublin, Ireland
- 4Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, Trinity College Dublin, Dublin, Ireland
- 5National Quality Improvement Team, Health Service Executive, Dr. Steevens Hospital, Dublin
- ↵*Corresponding author:
Dr Frank Moriarty, HRB Centre for Primary Care Research, Department of General Practice, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland., Tel: 353-1-402-8575 Email: frankmoriarty{at}rcsi.ie
Posted October 25, 2019.
Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study
